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Background
In the Romanian flora, several species of the Betula genus
are present, especially European white birch (B. pendula,
syn. B. verrucosa) and downy birch (B. pubescens, syn.
B. alba). Rare species are B. nana and B. humilis. In
Southern Romania, the sensitization to Betulaceae pollen
in patients with allergic rhinitis is less frequent than that
to Poaceae pollen. The flowering season of the birch trees
starts mostly in early April and lasts until mid of May,
while the grass flowering period starts in May and finishes
at the mid of July.
Methods
We enrolled subjects from Bucharest and the surrounding
counties in central part of Southern Romania, presenting
symptoms of rhinoconjunctivitis in early May (with or
without symptoms earlier in April) and having positive
skin prick tests to birch or Betulaceae tree pollen extracts,
with or without positive skin prick tests to mixed grass
pollen extract or Phleum pratense pollen extract. Serum
levels of specific IgE to birch pollen (t3), Timothy grass
pollen (g6), and to recombinant allergen components Bet
v 1, Bet v 2, Bet v 4, Bet v 6, Phl p 1, Phl p 5, Phl p 7, Phl
p 12 were measured using a novel multiparameter immu-
noblot test system based on single purified allergen com-
ponents (SPAC Pollen).
Results
Sera were collected from fourteen patients presenting
positive skin prick tests to Betulaceae mixed pollen
extract (100 IR/mL) and/or Betula alba pollen extract
(100 IR/mL). We found 85.71% patients with specific
IgE against Bet v 1 (genuine sensitization to birch pol-
len). For the rest, specific IgE to Phleum specific aller-
gen components (Phl p 1, Phl p 5) were detected, while
the birch-specific marker Bet v 1 being not recognized
by IgE antibodies. Moreover, 21.42% of all subjects were
co-sensitized to birch and grass pollen based on the pre-
sence of specific IgE to Phl p 1, Phl p 5 and Bet v 1.
Conclusion
Because birch trees and grasses may have a temporal over-
lap in flowering periods in some regions, and their pollen
grains contain cross-reactive allergen components (profi-
lins Bet v 2 and Phl p 12, polcalcins Bet v 4 and Phl p 7),
the in vitro diagnostic testing with the marker allergens
Bet v 1, Phl p 1, Phl p 5 allows the clinician to confirm
true sensitization to the corresponding allergen plant
sources for an accurate prescription of allergen-specific
immunotherapy. This is particularly important for South-
ern Romania, a region with a great plant biodiversity.
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